<DOC>
	<DOCNO>NCT00853099</DOCNO>
	<brief_summary>The purpose study assess efficacy safety adalimumab Japanese subject moderately severely active ulcerative colitis ( UC ) .</brief_summary>
	<brief_title>A Study Adalimumab Japanese Subjects With Moderately Severely Active Ulcerative Colitis</brief_title>
	<detailed_description>Patients meet inclusion criterion none exclusion criterion randomize 1:1:1 receive subcutaneous injection adalimumab either 160/80 mg Week 0/2 40 mg every week ( eow ) start Week 4 Week 50 , 80/40 mg Week 0/2 40 mg eow start Week 4 Week 50 , placebo eow start Week 0 Week 50 double-blind condition . At Week 8 , participant inadequate response double-blind period switch rescue arm , participant placebo group initially receive adalimumab 160 mg 80 mg 2 week later adalimumab group receive adalimumab 40 mg initially 2 week later double-blind condition . All participant rescue arm receive 40 mg adalimumab eow Week 50 . Participants complete 52-week double-blind period receive open-label adalimumab 40 mg eow start Week 52 continue end study . Participants inadequate response disease flare dose escalate 80 mg eow Week 60 . Participants dose escalate 80 mg eow continue inadequate response disease flare withdrawn study .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Diagnosis ulcerative colitis great 90 day prior Baseline . Active ulcerative colitis Mayo Score 612 point Baseline endoscopy subscore 23 Screening Period , despite concurrent treatment least one follow ( oral corticosteroid immunosuppressant define ) : Stable oral corticosteroid dose ( prednisolone dose ≥ 20 mg/day equivalent ) least 14 day prior Baseline stable oral corticosteroid dose ( prednisolone 5 less 20 mg/day ) least 40 day prior Baseline . And/or At least consecutive 90day course azathioprine 6mercaptopurine ( 6MP ) prior Baseline , dose azathioprine ≥ 50 mg/day 6MP ≥ 30 mg/day , dose high tolerated patient . History subtotal colectomy ileorectostomy colectomy ileoanal pouch , Koch pouch , ileostomy ulcerative colitis planning bowel surgery . Patients disease limit rectum . Indeterminate colitis and/or Crohn 's disease . Received biological therapy ( include infliximab ) past . History tuberculosis malignancy . Pregnant woman . Patients positive C. difficile stool assay Screening . Current diagnosis fulminant colitis and/or toxic megacolon .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Ulcerative Colitis</keyword>
</DOC>